(Q51035442)

27 March 2018

title

Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial. (English)

1 reference

27 March 2018

Antonio Pisani

1

0 references

author name string

Eleonora Riccio

2

1 reference

27 March 2018

Massimo Sabbatini

3

1 reference

27 March 2018

Michele Andreucci

4

1 reference

27 March 2018

Antonio Del Rio

5

1 reference

27 March 2018

Bianca Visciano

6

1 reference

27 March 2018

language of work or name

English

0 references

publication date

13 November 2014

1 reference

27 March 2018

Nephrology Dialysis Transplantation

published in

1 reference

27 March 2018

volume

30

1 reference

27 March 2018

issue

4

1 reference

27 March 2018

page(s)

645-652

1 reference

27 March 2018

Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

The FIND-CKD study--a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

A Randomized Controlled Trial of Oral versus Intravenous Iron in Chronic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Benchmarking iron dextran sensitivity: reactions requiring resuscitative medication in incident and prevalent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Parenteral iron therapy exacerbates experimental sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Use of parenteral iron products and serious anaphylactic-type reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Ferric carboxymaltose: a review of its use in iron-deficiency anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Ferumoxytol for treating iron deficiency anemia in CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Inflammation and resistance to treatment with recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Proteinuria induced by parenteral iron in chronic kidney disease--a comparative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU357

21 January 2018

Identifiers

DOI

10.1093/NDT/GFU357

1 reference

27 March 2018

1 reference

27 March 2018